Login
Toggle navigation
Videos
Categories
Trending
Focused on consumer technology and the consumerization of enterprise|Nikhil Basu Trivedi,Co-Founder and General Partner,Footwork
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Author of the next big thing (nbt.substack.com).
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
AMIS: Ensuring Accuracy and Quality in Mining Assays with Certified Reference Materials
00:00:00
Orthocell on the cusp of significant growth - Mr Paul Anderson Chief Executive Officer and Managing Director, Orthocell Ltd
00:10:00
"Robert F. Wallace on Managing Stanford's $35 Billion Investment Portfolio | Investment Conference 2024"
00:10:00
Michael Schwebel, Manager of Sustainability Consulting at NRG Energy, outlines initiatives addressing sustainability challenges.
00:10:00
Inside the Success of Platinum with Andrew Clifford | Andrew Clifford , CEO , Platinum Asset Management.
00:10:00
Opening Bell CSW Industrials On december 2015 | Joseph B. Armes, CEO, CSW Industrials IncCSWI:NSQ
00:10:00
Sahel Mining: Exploring a Vast Gold District in Western Africa
00:10:00
CEO Insights on Financial Stability and Regulatory Oversight | Bill Demchak, CEO, PNC Financial Services .
00:10:00
Interview with Don Bubar, President and CEO of Avalon Advanced Materials, at One-to-One Mining Conference
00:10:00
Efficient Document Management Boosts Productivity at Valeo Financial Advisors | Jhon Trott , Founder , Valeo Financial Advisors.
00:10:00
The CEO of secunet Security Networks AG, specialized in marketing, strategy, and sales, discusses his expertise.
00:10:00
Rethinking Tradition: Roger Kruse on IRS Practices | Roger C. Kruse - principal and founding partner of FFP Wealth Management